Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israël, Tel Aviv
Ari Raphael
29 années d'expérience
accréditations :
La clinique est certifiée :
En Israël, le NanoKnife coûte généralement de $18,500 à $31,500 selon la complexité tumorale et l'établissement choisi. Les tarifs dépendent de l'organe traité, du nombre d'électrodes et de la durée d'hospitalisation nécessaire. Les patients économisent environ 23% par rapport à la France, où l'acte coûte en moyenne $24,000. Les forfaits hospitaliers israéliens incluent souvent l'ablation, l'anesthésie, les bilans sanguins préopératoires et l'imagerie spécialisée comme le PET-scan PSMA.
Avis d'expert Bookimed : Opter pour un centre multidisciplinaire comme le Sourasky Medical Center (Ichilov) apporte une réelle valeur aux patients en oncologie. Bien que les forfaits NanoKnife y débutent autour de 27 550 €, ils offrent 90 % de taux de succès oncologique. Ichilov est accrédité par la JCI et figure au classement Newsweek des meilleurs hôpitaux mondiaux. Avec 34 000 opérations par an, l'établissement garantit une expertise chirurgicale approfondie. Pour les cas complexes, les spécialistes comme le professeur Jack Baniel offrent un accès à la recherche urologique mondiale. Les structures privées comme Assuta, facturées environ 38 700 €, privilégient des délais réduits et un service personnalisé en milieu accrédité JCI.
Pourquoi envisager Israël pour un traitement par nanoknife ?
Accédez à des solutions avancées de NanoKnife dans des cliniques de confiance .
| Israël | Turquie | Espagne | |
| NanoCouteau | de $18,500 | de $9,500 | de $12,000 |
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Barak Rosenzweig, MD, directs the Urological Oncology Service at Sheba Medical Center. He is a uro-oncologic surgeon with nearly 20 years of experience. He treats complex urologic cancers with advanced robotic and minimally invasive methods. He is listed among Israel’s Best Doctors by Forbes.
Expertise includes tumors of the prostate, kidney, bladder, testis, and upper urinary tract. He performs robotic radical prostatectomy, kidney-sparing partial nephrectomy, and advanced laparoscopy. Diagnostics include MRI-guided fusion biopsy and imaging-based personalized planning.
He completed a Urological Oncology fellowship at Memorial Sloan Kettering Cancer Center. He is a Senior Physician in the Department of Urology and a Clinical Senior Lecturer at Tel Aviv University. He is a graduate of the Sheba Talpiot program. He is an active researcher with over 200 publications in urologic oncology.
Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.
MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.
Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.
Expert de premier plan en technologie NanoKnife, spécialisé dans les tumeurs malignes thoraciques et le profilage génomique innovant au centre médical Sourasky.